2019

1. The SGLT2 inhibitor empagliflozin ameliorates the inflammatory profile in type 2 diabetic patients and promotes an antioxidant response in leukocytes

   Journal of Clinical Medicine, Vol. 8, Núm. 11

2. The mitochondria-targeted antioxidant MitoQ modulates mitochondrial function and endoplasmic reticulum stress in pancreatic β cells exposed to hyperglycaemia

   Cellular Physiology and Biochemistry, Vol. 52, Núm. 2, pp. 186-197